Certara · 1 day ago
Director of Commercial Finance Forecasting and Planning
United States
Full-time
Remote
Director/Executive
9+ years expCertara accelerates the potential of bringing medicines to market using biosimulation software and services. The Director of Commercial Finance Forecasting and Planning will serve as a strategic partner to the Chief Commercial Officer, focusing on financial performance and forecasting for software revenue and sales expenses.
BiotechnologyHealth CarePharmaceuticalSoftware
Responsibilities
Own forecast and budget for Certara’s Software Revenue & Sales and Marketing Expenses
Provide timely, accurate, and actionable financial reporting to support decision-making
Monitor and analyze the financial performance of commercial operations, identifying key drivers and areas for improvement
Lead the review of business plans and forecasts, identifying risks and opportunities
Drive integrated business planning
Drive continuous improvement projects to improve data quality, report automation, and process streamlining
Establish and track sales productivity metrics and improve forecasting by analyzing sales, tracking variances, and providing insights
Prepare materials for board meetings and other presentation support
Support commission calculations and design of sales compensation as required
Qualification
Required
Minimum of 9 years of experience in finance, including at least two years in a management position and a proven track record of driving change
At least 2-3 years of experience operating in a SaaS environment for a global software company. Sound understanding of the SaaS business model and key metrics (ARR, ACV, CAC, etc.)
Proven experience in a senior-level commercial finance role, with a strong understanding of revenue recognition policies
Extensive experience with presentations to senior management, with extraordinary detail orientation and strong data visualization skills
Experience with Salesforce required
Preferred
Experience with NetSuite is a plus
Company
Certara
Certara is a pharmaceutical company that accelerates medicines with biosimulation software and technology.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$844.17MKey Investors
Arsenal Capital PartnersMubadala
2025-03-28Post Ipo Equity· $5.67M
2023-08-29Grant
2022-11-07Post Ipo Secondary· $449M
Leadership Team
Daniel D. Corcoran
Senior Vice President and General Counsel
Rona Anhalt
Chief Human Resources Officer
Recent News
MarketScreener
2026-01-06
2026-01-03
2025-12-12
Company data provided by crunchbase